Chéry L - Search Results

1

Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance.

Gregg JR, Newcomb L, Wu R, Dennison J, Davis JW, Pettaway C, Pisters L, Ward JF, Chapin BF, Chéry L, Urkmez A, Fang AM, Higgason N, Troncoso P, Daniel CR, Logothetis C, Thompson TC, Hahn AW, Liu M, Zheng Y, Lin DW, Hanash S, Irajizad E, Fahrmann J. Gregg JR, et al. Among authors: chery l. Biomark Res. 2024 Nov 9;12(1):134. doi: 10.1186/s40364-024-00678-7. Biomark Res. 2024. PMID: 39522029 Free PMC article.

2

Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer.

Fang AM, Jackson J, Gregg JR, Chery L, Tang C, Surasi DS, Siddiqui BA, Rais-Bahrami S, Bathala T, Chapin BF. Fang AM, et al. Among authors: chery l. Curr Treat Options Oncol. 2024 Jan;25(1):66-83. doi: 10.1007/s11864-023-01162-4. Epub 2024 Jan 3. Curr Treat Options Oncol. 2024. PMID: 38212510 Review.

3

A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates.

Hahn AW, Manyam GC, Chapin BF, Zhang M, Yu Y, Pettaway CA, Chery L, Pisters LL, Ward JF, Gregg JR, Papadopoulos J, Kamat AM, Lozano M, Hoang A, Broom B, Wang X, Huff CD, Logothetis CJ, Troncoso P, Pilié PG, Davis JW. Hahn AW, et al. Among authors: chery l. BJU Int. 2024 Sep;134(3):449-458. doi: 10.1111/bju.16414. Epub 2024 Jun 4. BJU Int. 2024. PMID: 38837608 Clinical Trial.

4

Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer.

McCormick BZ, Chery L, Chapin BF. McCormick BZ, et al. Among authors: chery l. Transl Androl Urol. 2021 May;10(5):2178-2187. doi: 10.21037/tau-20-1002. Transl Androl Urol. 2021. PMID: 34159100 Free PMC article. Review.

5

Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.

Macleod LC, Chery LJ, Hu EY, Zeliadt SB, Holt SK, Lin DW, Porter MP, Gore JL, Wright JL. Macleod LC, et al. Among authors: chery lj. Prostate Cancer Prostatic Dis. 2015 Jun;18(2):190-5. doi: 10.1038/pcan.2015.12. Epub 2015 Mar 31. Prostate Cancer Prostatic Dis. 2015. PMID: 25823651

6

Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status.

Wright JL, Chéry L, Holt S, Lin DW, Luedeke M, Rinckleb AE, Maier C, Stanford JL. Wright JL, et al. Among authors: chery l. Prostate Cancer Prostatic Dis. 2016 Mar;19(1):53-6. doi: 10.1038/pcan.2015.49. Epub 2015 Oct 27. Prostate Cancer Prostatic Dis. 2016. PMID: 26503111 Free PMC article.

7

Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia.

Cheng HH, Mitchell PS, Kroh EM, Dowell AE, Chéry L, Siddiqui J, Nelson PS, Vessella RL, Knudsen BS, Chinnaiyan AM, Pienta KJ, Morrissey C, Tewari M. Cheng HH, et al. Among authors: chery l. PLoS One. 2013 Jul 30;8(7):e69239. doi: 10.1371/journal.pone.0069239. Print 2013. PLoS One. 2013. PMID: 23935962 Free PMC article.

8

Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy.

Borregales LD, Adibi M, Thomas AZ, Reis RB, Chery LJ, Devine CE, Wang X, Potretzke AM, Potretzke T, Figenshau RS, Bauman TM, Aboshady YI, Abel EJ, Matin SF, Karam JA, Wood CG. Borregales LD, et al. Eur Urol Focus. 2021 Mar;7(2):397-403. doi: 10.1016/j.euf.2019.10.007. Epub 2019 Nov 2. Eur Urol Focus. 2021. PMID: 31685445

9

Cytoreductive nephrectomy for metastatic renal cell carcinoma.

Chery LJ, Karam JA, Wood CG. Chery LJ, et al. Clin Adv Hematol Oncol. 2016 Sep;14(9):696-703. Clin Adv Hematol Oncol. 2016. PMID: 27673288 Review.

10

Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.

Labbate CV, Hensley PJ, Miest TS, Qiao W, Adibi M, Shah AY, Chery L, Papadopoulos J, Siefker-Radtke AO, Gao J, Guo CC, Czerniak BA, Navai N, Kamat AM, Dinney CP, Campbell MT, Matin SF. Labbate CV, et al. Among authors: chery l. Urol Oncol. 2022 Oct;40(10):454.e17-454.e23. doi: 10.1016/j.urolonc.2022.06.014. Epub 2022 Aug 10. Urol Oncol. 2022. PMID: 35961847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters